ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.

Andrea B Apolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.